Neoadjuvant immunotherapy improves outcomes in high-risk melanoma patients.

Published Date: 02 Mar 2023

High-risk melanoma patients who received the drug pembrolizumab before or after surgery to remove the cancer had a higher risk of developing melanoma than those who did not have a similar condition that eliminated cancer cells.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Personalized Breast Cancer Treatment; Insights Into HPV in Men; Exercise and Cancer

2.

In heavily pretreated DLBCL, Triplet Scores a Survival Victory.

3.

Chronic stress and obesity work together to accelerate pancreatic cancer development and growth, study finds

4.

Efanesoctocog Alfa Prevented Bleeding in Kids With Severe Hemophilia A

5.

Eight Doctors Killed in Brazil's Horrifying Plane Crash


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot